Paula Rodriguez-Otero

45PUBLICATIONS
267CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical mycologyHaematological tumoursMolecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (45)

|Aug 06, 2026
Talquetamab in patients with relapsed/refractory multiple myeloma: 3-year follow-up of the phase 1/2 MonumenTAL-1 study.

|Jul 24, 2026
MRD dynamics predicts progression and reveals a vulnerable state for immunotherapy interception in multiple myeloma.

|Jul 02, 2026
Multiple myeloma: A tale of deregulated transcription factors.

|Jun 23, 2026
Stromal and endothelial transcriptional changes during progression from MGUS to myeloma and after treatment response.

|Jun 22, 2026
Minimally invasive characterization of peripheral blood measurable residual disease in multiple myeloma using high-sensitivity detection of ctDNA by next-generation sequencing.

|Jun 05, 2026
IRF2 is an essential transcription factor with pathogenic and prognostic impact in multiple myeloma.

Pageof 8

Frequent Collaborators

20 joint publications

María-Victoria Mateos

20 joint publications

Bruno Paiva

19 joint publications

Jesus San-Miguel

13 joint publications

Laura Rosiñol